+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 100 Actively Recruiting clinical trials

S

Actively Recruiting

Healthy Volunteer

Researchers are evaluating three different impression techniques for making 3D-printed mandibular implant overdentures in patients who have lost all their lower teeth. This randomized crossover trial involves sixteen patients aged 45 to 70 years who will receive two implants in the lower jaw. The study aims to compare how these techniques influence chewing efficiency and patient satisfaction. The three impression methods being studied are conventional open-tray implant-level impression, functionally generated reline impression, and mucostatic base with functional borders impression. Each participant will wear three different overdentures made using these techniques, each for three months. Between each overdenture period, there is a two-week washout phase during which a provisional denture is worn. The order of techniques is randomly assigned for each patient. Participants will undergo assessments at 3, 6, and 9 months after overdenture insertion. Chewing efficiency will be measured using a color-mixing ability test, and patient satisfaction will be recorded using a Visual Analog Scale. The study includes clinical evaluations and questionnaires to monitor the effects of each impression technique on both function and patient experience.

Age: 45Years +All GendersPhase Not Applicable
1 location
O

Actively Recruiting

Diffuse large B-cell lymphoma DLBCL is the most common and aggressive subtype of non-Hodgkin lymphoma NHL, affecting many patients with rapid tumor growth and symptoms depending on tumor location. This observational study aims to understand the clinical characteristics, treatment patterns, and access to new therapies for patients with DLBCL in the Middle East and Africa region, including both newly diagnosed and relapsed or refractory cases. Participants are grouped into two cohorts those who are newly diagnosed and eligible for treatment, and those who have relapsed or are refractory after at least one prior therapy. The study does not involve experimental treatments but collects information on how patients are treated in real-world settings and explores access to innovative therapies. During the study, patient demographics, disease characteristics, risk profiles, and treatment patterns are documented over 22 months. Researchers will gather data through reviews of medical records and clinical information without administering treatments. The primary goal is to describe first-line and subsequent treatment approaches and to understand patient access to novel therapies for DLBCL.

All AgesAll Genders
21 locations
S

Actively Recruiting

This research aims to evaluate the effectiveness, safety, and tolerability of combining baxdrostat with dapagliflozin compared to dapagliflozin alone in people with chronic kidney disease CKD and high blood pressure. The goal is to reduce the risk of serious kidney problems, heart failure events, or cardiovascular death. This is a phase III, international, multicenter, randomized, double-blind, placebo-controlled, event-driven study focused on treatment outcomes. Participants who do not already use SGLT2 inhibitors will first undergo a 4-week dapagliflozin run-in period. After that, they will be randomly assigned to receive either baxdrostat plus dapagliflozin or placebo plus dapagliflozin. Baxdrostat dosing may start low and be increased if needed. Study visits will occur frequently early on at 2, 4, 8, 16, 34, and 52 weeks post-randomization, then approximately every 4 months. The study will end when a predetermined number of kidney or cardiovascular events occur. During the study, participants will have scheduled visits for assessments including kidney function, heart health, and safety monitoring. If they stop the study treatment early, they will continue on dapagliflozin alone and remain in the trial for follow-up visits. Researchers will measure outcomes such as sustained kidney function decline, kidney failure, heart failure events, cardiovascular death, and all-cause death over up to 37 months. Data collection continues until the study closes, with safety and tolerability closely observed throughout.

Age: 18Years +All GendersPhase 3
771 locations
P

Actively Recruiting

Researchers are evaluating the safety and preliminary effectiveness of oral roflumilast in adults with moderate-to-severe plaque psoriasis in this 12-week pilot study. The study focuses on measuring changes in psoriasis severity using the Psoriasis Area and Severity Index PASI score and includes monitoring changes in body mass index BMI. Both male and female participants will be included and analyzed as subgroups to better understand treatment effects. All participants will receive oral roflumilast starting at 250 mcg once daily for the first 10 days, followed by an increased dose of 500 mcg once daily for the remaining weeks, totaling 12 weeks of treatment. There is no placebo or comparison group. The study is open-label and single-arm, meaning all participants know they receive the active drug. Participants will undergo detailed medical history reviews and clinical exams before starting treatment. During the 12 weeks, they will attend scheduled visits for assessments of psoriasis severity, BMI, and safety monitoring including adverse events and laboratory tests. Data will be collected and analyzed overall and by sex-based subgroups to evaluate treatment effects and safety.

Age: 18Years +All GendersPhase 2
1 location
P

Actively Recruiting

Researchers are evaluating intra-lesional immunotherapy using the measles-mumps-rubella MMR vaccine as a treatment for recalcitrant tinea cruris and corporis. This condition involves persistent fungal infections that have not improved with standard antifungal treatments. The study targets patients aged 10 to 60 years who have experienced rapid progression, large affected skin areas, infections in multiple family members, rapid relapse, or suspected resistant strains of the fungus. The purpose is to assess the safety and therapeutic effect of this novel immunotherapy in a pilot setting. Participants will receive injections of the MMR vaccine directly into the active borders of their fungal lesions every two weeks for six weeks. If there is partial improvement but not full clearance after the initial treatment, the course may be extended for an additional six weeks, with up to six injection sessions total. In addition, patients will take pulse itraconazole during the first two weeks of the study. All participants receive the same treatment without a comparison or placebo group. Throughout the study, clinicians will monitor skin involvement and symptoms such as itching at each visit every two weeks, up to 6 weeks, with possible extension to 12 weeks if treatment continues. Safety assessments will track injection site reactions, fevers, lesion flares, and any rare serious allergic effects. The main outcome will be the percent reduction in the affected body surface area. Safety and tolerance of the injections will be observed continuously during treatment and extension periods. Participants are expected to be involved for up to 12 weeks in total.

Age: 10Years - 60YearsAll GendersPhase Not Applicable
1 location
C

Actively Recruiting

This research investigates the accuracy of two different methods for taking dental implant impressions in patients who have lost all their teeth and are receiving full-arch implant-supported prostheses. It focuses on comparing the conventional splinted open-tray impression technique with a digital intraoral scanning method that uses a calibrated framework. Achieving a precise transfer of implant positions is vital to ensure proper fit and to reduce biological and mechanical complications in implant rehabilitation. Twenty healthy patients without teeth in both jaws will participate. Each will undergo both impression methods after implant placement. The conventional method involves making a splinted open-tray impression using dental floss and resin, followed by a polyvinyl siloxane impression and laboratory scanning. The digital method uses an intraoral scanner combined with a calibrated stock framework attached to implant scan bodies to capture the implant positions. Both resulting digital files will be analyzed and compared for accuracy using specialized software. Participants will have both procedures done during the same study visit following implant placement. The study team will measure linear, angular, and overall deviations between the two techniques by superimposing the digital models. This will help determine if the digital scanning with a calibrated framework matches or improves upon the conventional impression accuracy. The study will monitor these outcomes immediately after the impression procedures, with no additional long-term follow-up described.

Age: 35Years - 60YearsAll GendersPhase Not Applicable
1 location
S

Actively Recruiting

This research aims to evaluate the use of activated charcoal in managing hyperphosphatemia, a condition common in patients with end-stage renal disease ESRD who are on dialysis. Hyperphosphatemia can contribute to worsening vascular calcification, and current management mainly involves limiting dietary phosphorus and using phosphate binders. Activated charcoal, which is generally well tolerated, is being studied as a possible alternative to conventional phosphate binders in dialysis patients. Participants are randomly assigned to one of two groups one group receives standard care with calcium-based or non-calcium based phosphate binders such as sevelamer, while the other group receives these standard binders plus oral activated charcoal capsules taken with meals. The study is double-blinded and conducted over 8 weeks to assess the effect of activated charcoal on mineral and bone disorder related to chronic kidney disease. During the study, participants will have their serum phosphorus levels measured to evaluate treatment effects. Researchers will also track the percentage of patients who experience a significant decrease in itching intensity using a numerical rating scale. The study includes safety monitoring and aims to gather data on both efficacy and side effects. Overall participation duration includes screening, treatment, and follow-up during the 8-week trial period.

Age: 18Years +All GendersPhase 2
1 location
C

Actively Recruiting

Researchers are evaluating the effectiveness of acupuncture and transcutaneous electrical nerve stimulation TENS as physical therapy approaches to reduce pain following upper abdominal surgeries, such as laparoscopic cholecystectomy and gastrectomy. This study aims to compare the safety and pain-reducing benefits of these two methods to provide guidance for postoperative pain management. Participants will be randomly assigned to one of two groups one will receive acupuncture treatment three times a week for four weeks alongside standard medical care, and the other will receive TENS therapy with the same frequency and duration plus medical treatment. Acupuncture involves needle insertion at specific points with manipulation to induce sensations like soreness or numbness, starting within two hours after surgery and continuing daily for gastrectomy patients. TENS treatment uses a device providing electrical stimulation for up to 48 hours post-surgery, with patients adjusting intensity for pain relief. During the study, participants recovery quality and pressure pain threshold will be measured at the start and after four weeks. Assessments include monitoring pain levels, physical therapy effects, and safety. The total participation period spans four weeks, with ongoing evaluations to determine changes in postoperative pain and recovery.

Age: 20Years - 45YearsAll GendersPhase Not Applicable
1 location
I

Actively Recruiting

Researchers are investigating autoinflammatory diseases AID, which involve recurring inflammatory episodes without infection, cancer, or adaptive immune system problems. This study focuses on both monogenic hereditary periodic syndromes and polygenic or multifactorial AID, including rare conditions like Behets disease, Still disease, Schnitzlers disease, PFAPA syndrome, chronic recurrent multifocal osteomyelitis, non-infectious uveitis and scleritis, among others. The goal is to gather detailed data to improve understanding and management of these rare diseases through an international collaboration. The study uses the AIDA registry, a secure online platform for collecting demographic, genetic, clinical, laboratory, radiologic, and therapeutic information. Data are gathered retrospectively and prospectively during routine clinical visits scheduled every 3-6 months. Eleven registries focus on different AID conditions, enabling comprehensive data collection to identify clinical patterns, treatment impacts, and long-term outcomes over a period of at least 10 years. Participants provide information during their usual care visits, allowing researchers to track changes in disease activity, organ involvement, inflammatory markers, visual function, pain levels, fatigue, fertility, and socioeconomic factors. The study monitors these outcomes over multiple timepoints up to 120 months. Data privacy is ensured by pseudonymizing patient information. This registry supports multiple clinical studies and aims to enhance knowledge, awareness, and future research on autoinflammatory diseases worldwide.

All AgesAll Genders
112 locations
S

Actively Recruiting

Researchers are evaluating the biomechanical effects of digitally designed subperiosteal implants made from different materials on the atrophied upper jaw bone maxilla. These implants are considered for patients with advanced bone loss where traditional implants may not be suitable. The study aims to understand which implant material could be best suited for this condition, as there is limited evidence regarding the optimal material choice. The study compares virtual designs of subperiosteal implant frameworks made from three materials titanium, PEEK, and PEKK. These frameworks are digitally constructed for use on the atrophied maxilla bone. A 3D image of the patients upper jaw bone is created from a computed tomography scan and processed into a digital model. This model is used to simulate force loading between the implant parts, screws, and bone tissues to analyze biomechanical behavior. Participants will contribute by providing their computed tomography scan data that produces the 3D image of their edentulous maxilla bone. Researchers will analyze bone loss under the implants over a period of 10 to 15 years using digital simulation methods. The study is observational and does not involve direct treatment but focuses on evaluating implant framework materials and prosthetic superstructures in the digital environment. The trial includes adults aged 30 to 70 with specific bone classifications of the maxilla.

Age: 30Years - 70YearsAll Genders
1 location

1-10 of 100

1